Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)
Journal: International Journal of Clinical Pharmacology & Toxicology (IJCPT) (Vol.01, No. 01)Publication Date: 2012-10-01
Authors : Prof Gerard Siest;
Page : 01--
Keywords : Pharmacogenomic Information; Generic Medications; European Society of Pharmacogenomics and Theranostics (ESPT);
Abstract
As of 2007, PLAVIX (the original brand name of Clopidogrel) had been the second top selling drug in the world and is, presently, prescribed and marketed in nearly 110 countries. Clopidogrel is currently the thienopyridine of choice for dual antiplatelet therapy (in combination with aspirin) in patients with the full spectrum of acute coronary syndrome and in patients undergoing percutaneous coronary intervention and stenting.
Other Latest Articles
- The Discovery of Insulin and the Future for Insulin Replacement Therapy
- Design and Analysis of Recommender System for Business Data
- Evolving a Ultra-Flow Software Development Life Cycle Model
- ???? EMI ?? ????? ?? ???? ????? ???? ?? ?? ?????????? ??? ????????? ???? ???????
- ????? ???? ?????? ?? ?????? ????? ?? ???? ????? ?? ?????? ?? ??????? ?? ??????? ???? ????
Last modified: 2015-07-18 13:24:44